Pricing strategy: The pharmaceutical companies that produce GLP-1 drugs for weight loss have chosen a pricing strategy that focuses on maximizing profit from a smaller patient population rather than pursuing a lower profit margin across a larger customer base
Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up
The Medical Weight Loss and GLP-1 Treatment Program at Taylor Bariatric Institute is fundamentally different
Genetic testing for the following syndromes (if your child has certain dysmorphic features or characteristics): Tuberous Sclerosis Complex, Angelman, PraderWilli, Velocardiofacial, and Smith-Lemli-Opitz syndromes Testing for Mitochondrial Dysfunction and Cerebral Folate Deficiency, metabolic disorders with a high prevalence among individuals with ASD and seizures If supporting clinical characteristics exist, consider testing for other, much more rare metabolic disorders, such as: Succinic Semialdehyde Dehydrogenase Deficiency, Adenylosuccinate lyase deficiency, Creatine Metabolism Disorder, Phenylketonuria, Pyridoxine dependent and responsive seizures, and Urea Cycle Disorders Treatment Options for Seizures Seizures are most commonly treated with anti-epileptic drugs (AEDs), but non-AED treatments are also available
.jpg)
